| Standardization and quality control studies of ‘real-time’quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection … J Gabert, E Beillard, VHJ Van der Velden, W Bi, D Grimwade, ... Leukemia 17 (12), 2318-2357, 2003 | 1901 | 2003 |
| Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood JJM van Dongen, T Seriu, ER Panzer-Grümayer, A Biondi, ... The Lancet 352 (9142), 1731-1738, 1998 | 1168 | 1998 |
| Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the … V Conter, CR Bartram, MG Valsecchi, A Schrauder, R Panzer-Grümayer, ... Blood, The Journal of the American Society of Hematology 115 (16), 3206-3214, 2010 | 932 | 2010 |
| Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects VHJ Van der Velden, A Hochhaus, G Cazzaniga, T Szczepanski, J Gabert, ... Leukemia 17 (6), 1013-1034, 2003 | 848 | 2003 |
| Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR data VHJ Van der Velden, G Cazzaniga, A Schrauder, J Hancock, P Bader, ... Leukemia 21 (4), 604-611, 2007 | 836 | 2007 |
| Prenatal origin of acute lymphoblastic leukaemia in children JL Wiemels, G Cazzaniga, M Daniotti, OB Eden, GM Addison, G Masera, ... The Lancet 354 (9189), 1499-1503, 1999 | 797 | 1999 |
| The MLL recombinome of acute leukemias in 2017 C Meyer, T Burmeister, D Gröger, G Tsaur, L Fechina, A Renneville, ... Leukemia 32 (2), 273-284, 2018 | 664 | 2018 |
| The MLL recombinome of acute leukemias in 2013 C Meyer, J Hofmann, T Burmeister, D Gröger, TS Park, M Emerenciano, ... Leukemia 27 (11), 2165-2176, 2013 | 562 | 2013 |
| Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international … T Flohr, A Schrauder, G Cazzaniga, R Panzer-Grümayer, ... Leukemia 22 (4), 771-782, 2008 | 520 | 2008 |
| Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study M Schrappe, MG Valsecchi, CR Bartram, A Schrauder, ... Blood, The Journal of the American Society of Hematology 118 (8), 2077-2084, 2011 | 508 | 2011 |
| Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia E Flex, V Petrangeli, L Stella, S Chiaretti, T Hornakova, L Knoops, ... The Journal of experimental medicine 205 (4), 751-758, 2008 | 456 | 2008 |
| RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia E Papaemmanuil, I Rapado, Y Li, NE Potter, DC Wedge, J Tubio, ... Nature genetics 46 (2), 116-125, 2014 | 404 | 2014 |
| Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias C Shochat, N Tal, OR Bandapalli, C Palmi, I Ganmore, G te Kronnie, ... Journal of Experimental Medicine 208 (5), 901-908, 2011 | 401 | 2011 |
| Incidence and clinical relevance of TEL/AML1 fusion genes in children with acute lymphoblastic leukemia enrolled in the German and Italian multicenter therapy trials A Borkhardt, G Cazzaniga, S Viehmann, MG Valsecchi, WD Ludwig, ... Blood, The Journal of the American Society of Hematology 90 (2), 571-577, 1997 | 395 | 1997 |
| Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome D Bercovich, I Ganmore, LM Scott, G Wainreb, Y Birger, A Elimelech, ... The Lancet 372 (9648), 1484-1492, 2008 | 391 | 2008 |
| Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report … L Hertzberg, E Vendramini, I Ganmore, G Cazzaniga, M Schmitz, ... Blood, The Journal of the American Society of Hematology 115 (5), 1006-1017, 2010 | 384 | 2010 |
| Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations P Gorello, G Cazzaniga, F Alberti, MG Dell'Oro, E Gottardi, G Specchia, ... Leukemia 20 (6), 1103-1108, 2006 | 361 | 2006 |
| Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+ AML B Falini, N Bolli, J Shan, MP Martelli, A Liso, A Pucciarini, B Bigerna, ... Blood 107 (11), 4514-4523, 2006 | 360 | 2006 |
| Genetic evidence for lineage-related and differentiation stage–related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia M Tartaglia, S Martinelli, G Cazzaniga, V Cordeddu, I Iavarone, M Spinelli, ... Blood 104 (2), 307-313, 2004 | 332 | 2004 |
| Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia C Eckert, A Biondi, K Seeger, G Cazzaniga, R Hartmann, B Beyermann, ... The Lancet 358 (9289), 1239-1241, 2001 | 291 | 2001 |
